Perforomist Solution
Product Images NDC 49502-605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Perforomist (NDC 49502-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (688e213e 4122 4bae 8da8 80f0548e9716 01)

Structural Formula (688e213e 4122 4bae 8da8 80f0548e9716 01)
Chemical structure diagram of formoterol fumarate dihydrate, the active ingredient in Perforomist inhalation solution. The diagram shows the molecular components and hydration state of the compound.*
FDA Label Image

Perforomist Figure 1 (688e213e 4122 4bae 8da8 80f0548e9716 02)

Perforomist Figure 1 (688e213e 4122 4bae 8da8 80f0548e9716 02)
A line graph comparing mean FEV1 (forced expiratory volume in 1 second) in liters over 12 hours between Perforomist 20 mcg and placebo. The x-axis shows hours from 0 to 12, and the y-axis shows mean FEV1 in liters from 1.20 to 1.80. The graph includes data series for Perforomist 20 mcg (N=123) and placebo (N=114).*
FDA Label Image

Perforomist Figure 2 (688e213e 4122 4bae 8da8 80f0548e9716 03)

Perforomist Figure 2 (688e213e 4122 4bae 8da8 80f0548e9716 03)
A line chart comparing mean FEV1 (in liters) over 12 hours between Perforomist 20 mcg (N=123) and placebo (N=114). The x-axis represents time in hours, while the y-axis shows mean FEV1 values. The Perforomist group shows higher FEV1 values throughout the time points compared to placebo.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
An instructional illustration showing the use of an inhalation device. The image depicts hands holding a medication pen and positioning it vertically over a circular inhaler base, indicating the proper method to prepare or load the device for respiratory administration.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
An instructional illustration showing how to use the Perforomist inhalation solution device. It depicts a hand holding the inhaler with a close-up of the nozzle tip, indicating proper administration technique for respiratory inhalation.*
FDA Label Image

Figures 3 And 4 (Image 03)

Figures 3 And 4 (Image 03)
Two-panel instructional diagram showing correct usage of Perforomist solution for respiratory inhalation. The left panel depicts a person inhaling directly from the inhaler mouthpiece, while the right panel shows a person inhaling through a facemask attachment connected to the device.*
FDA Label Image

Perforomist Inhalation Solution 20 Mcg/2 mL Carton Label (Image 04)

Perforomist Inhalation Solution 20 Mcg/2 mL Carton Label (Image 04)
Perforomist (formoterol fumarate) Inhalation Solution 20 mcg/2 mL vial carton label. The label is for sterile unit dose vials for oral inhalation only. Each carton contains 30 individually wrapped 2 mL vials. The labeler is Mylan, with the NDC 49502-605-30. Additional text includes patient information, inactive ingredients, and packaging instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.